{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:46:33Z","timestamp":1777416393512,"version":"3.51.4"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe acute respiratory syndrome coronavirus 2 infection has caused significant morbidity and mortality. Vaccines produced against this virus have proven highly effective. However, adverse events following vaccination have also been reported. One of them is nephrotic syndrome, that can be associated with different pathologic pictures. This review aims to provide a wider understanding of incidence, etiopathogenesis, and management of nephrotic syndrome following vaccination\u00a0against SARS-CoV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A literature search was undertaken using appropriate keywords in various databases like PubMed, Google Scholar, Europe PMC, and Science Direct. Twenty-one articles were included following qualitative assessment. Data of 74 patients from these articles were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The pathogenesis of nephrotic syndrome following COVID vaccination has been widely attributed to the activation of angiotensin-converting enzyme-2 receptors, leading to podocyte effacement. Relapses have\u00a0also been reported in patients with prior history of nephrotic syndrome following COVID-19 vaccination. A renal biopsy is necessary to identify the histopathological picture. Management of COVID-19 vaccine-induced nephrotic syndrome was mainly reported as successfully attainable\u00a0with corticosteroids and supportive management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Further investigations will help in establishing an early diagnosis and salvaging kidney function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-023-01710-z","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T11:01:26Z","timestamp":1690542086000},"page":"2431-2440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nephrotic syndrome following COVID-19 vaccination: a systematic review"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4749-6686","authenticated-orcid":false,"given":"Charmy","family":"Parikh","sequence":"first","affiliation":[{"name":"Pramukhswami Medical College, Anand, Gujarat, India 1"},{"name":"Carle BroMenn Medical Center, Normal, Illinois, USA 2"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8314-8403","authenticated-orcid":false,"given":"Henil","family":"Upadhyay","sequence":"additional","affiliation":[{"name":"Pramukhswami Medical College, Anand, Gujarat, India 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0245-8229","authenticated-orcid":false,"given":"Suyog","family":"Patel","sequence":"additional","affiliation":[{"name":"B.J. Medical College, Ahmedabad, Gujarat, India 3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-6036","authenticated-orcid":false,"given":"Ramaswamy","family":"Sundararajan","sequence":"additional","affiliation":[{"name":"JSS Medical College (JSS Academy of Higher Education and Research), Mysore, Karnataka, India 4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-6707","authenticated-orcid":false,"given":"Dhairya","family":"Shah","sequence":"additional","affiliation":[{"name":"GMERS Medical College, Vadodara, Gujarat, India 5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0279-4636","authenticated-orcid":false,"given":"Ayush","family":"Anand","sequence":"additional","affiliation":[{"name":"BP Koirala Institute of Health Sciences, Dharan, Nepal 6"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-1523","authenticated-orcid":false,"given":"Bhavana","family":"Baraskar","sequence":"additional","affiliation":[{"name":"Index Medical College Hospital and Research Centre, Indore, Madhya Pradesh, India 7"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-7551","authenticated-orcid":false,"given":"Tulsi","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Pramukhswami Medical College, Anand, Gujarat, India 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5474-6065","authenticated-orcid":false,"given":"Deepak","family":"Verma","sequence":"additional","affiliation":[{"name":"Janaki Medical College, Dhanusha, Nepal 8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubham","family":"Agrawal","sequence":"additional","affiliation":[{"name":"PGY-2, Mercy Catholic Medical Center, Upper Darby, PA, USA 9"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amol","family":"Mittal","sequence":"additional","affiliation":[{"name":"Westchester Medical Center, Valhalla, USA 10"},{"name":"New York Medical College, Valhalla, USA 11"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Gupta","sequence":"additional","affiliation":[{"name":"Westchester Medical Center, Valhalla, USA 10"},{"name":"New York Medical College, Valhalla, USA 11"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"issue":"19","key":"2026012110230071000_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2020","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"2026012110230071000_CR2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"2026012110230071000_CR3"},{"issue":"8","key":"2026012110230071000_CR4","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/pathogens10081030","article-title":"An overview of vaccines against SARS-CoV-2 in the COVID-19 pandemic era","volume":"10","author":"Pascual-Iglesias","year":"2021","journal-title":"Pathogens"},{"key":"2026012110230071000_CR5"},{"key":"2026012110230071000_CR6"},{"issue":"11","key":"2026012110230071000_CR7","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1111\/bcp.14581","article-title":"COVID-19 vaccines: the importance of transparency and fact-based education","volume":"86","author":"Cohen","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"2026012110230071000_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.ajkd.2021.06.004","article-title":"De novo and relapsing glomerular diseases after COVID-19 vaccination: what do we know so far?","volume":"78","author":"Bomback","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2026012110230071000_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/j.ajkd.2021.06.008","article-title":"Minimal change disease with severe acute kidney injury following the oxford-astrazeneca COVID-19 vaccine: a case report","volume":"78","author":"Leclerc","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2026012110230071000_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"2026012110230071000_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/j.ajkd.2021.03.010","article-title":"Minimal change disease following the Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Lebedev","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2026012110230071000_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5003","article-title":"Minimal change nephrotic syndrome four days after the administration of Pfizer-BioNTech COVID-19 vaccine\u2014a new side effect or coincidence?","author":"Abdulgayoom","year":"2021","journal-title":"Clin Case Rep"},{"key":"2026012110230071000_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02583-9","article-title":"Minimal change disease following the Moderna COVID-19 vaccine: first case report","author":"Thappy","year":"2021","journal-title":"BMC Nephrol"},{"key":"2026012110230071000_CR14","doi-asserted-by":"publisher","first-page":"205435812110582","DOI":"10.1177\/20543581211058271","article-title":"Minimal change disease after first dose of Pfizer-BioNTech COVID-19 vaccine: a case report and review of minimal change disease related to COVID-19 vaccine","volume":"8","author":"Hanna","year":"2021","journal-title":"Can J Kidney Health Dis"},{"key":"2026012110230071000_CR15","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e218","article-title":"New-onset nephrotic syndrome after Janssen COVID-19 vaccination: a case report and literature review","author":"Lim","year":"2021","journal-title":"J Korean Med Sci"},{"key":"2026012110230071000_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab156","article-title":"Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination","author":"Kobayashi","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026012110230071000_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab155","article-title":"Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine","author":"Unver","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026012110230071000_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab153","article-title":"Adult-onset nephrotic syndrome following COVID-19 vaccination","author":"Biradar","year":"2021","journal-title":"Clin Kidney J"},{"issue":"2","key":"2026012110230071000_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13730-021-00656-0","article-title":"New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review","volume":"11","author":"Nakazawa","year":"2021","journal-title":"CEN Case Rep"},{"issue":"3","key":"2026012110230071000_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244638","article-title":"Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases","volume":"15","author":"Hartley","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"1","key":"2026012110230071000_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/medicina58010037","article-title":"De novo minimal change disease following vaccination with the Pfizer\/BioNTech SARS-CoV-2 vaccine in a living kidney donor","volume":"58","author":"Marinaki","year":"2021","journal-title":"Medicina"},{"issue":"12","key":"2026012110230071000_CR22","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.ekir.2021.09.008","article-title":"COVID-19 vaccination and glomerulonephritis","volume":"6","author":"Klomjit","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"1","key":"2026012110230071000_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000521981","article-title":"De novo minimal change disease in an adolescent after Pfizer-BioNTech COVID-19 vaccination: a case report","volume":"12","author":"Pella","year":"2022","journal-title":"Case Rep Nephrol Dial"},{"key":"2026012110230071000_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac067.029","article-title":"MO230: de novo double glomerulopathy (Membranous Nephropathy, Mn and Collapsing Focal Segmental Glomerulosclerosis, CFSGS) associated to positive myeloperoxidase-O (MPO) antibody following pfizer-biontech MRNA vaccination Covid 19","author":"Marega","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2026012110230071000_CR25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24245","article-title":"A Case of membranous nephropathy hypothesized to be associated with COVID-19 vaccine","author":"Rashid","year":"2022","journal-title":"Cureus."},{"issue":"4","key":"2026012110230071000_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000523962","article-title":"New onset biopsy-proven nephropathies after COVID vaccination","volume":"53","author":"Fenoglio","year":"2022","journal-title":"Am J Nephrol"},{"key":"2026012110230071000_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-021-01091-1","article-title":"Minimal change disease following vaccination for SARS-CoV-2","author":"Mancianti","year":"2021","journal-title":"J Nephrol"},{"key":"2026012110230071000_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-022-00702-5","article-title":"A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose","author":"Mochizuki","year":"2022","journal-title":"CEN Case Rep."},{"issue":"01","key":"2026012110230071000_CR29","doi-asserted-by":"publisher","first-page":"031","DOI":"10.1055\/s-0042-1743209","article-title":"A case of minimal change disease after SARS-CoV-2 vaccination under the age of 18","volume":"12","author":"Alhosaini","year":"2022","journal-title":"Avicenna J Med"},{"key":"2026012110230071000_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac134","article-title":"Idiopathic nephrotic syndrome relapse following COVID-19 vaccination: a series of 25 cases","author":"Hummel","year":"2022","journal-title":"Clin Kidney J"},{"issue":"9","key":"2026012110230071000_CR31","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/ndt\/gfab215","article-title":"Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?","volume":"36","author":"Izzedine","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026012110230071000_CR32","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"2026012110230071000_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-022-00695-1","article-title":"Development of IgA vasculitis with severe glomerulonephritis after COVID-19 vaccination: a case report and literature review","author":"Sugita","year":"2022","journal-title":"CEN Case Rep"},{"issue":"11","key":"2026012110230071000_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-247188","article-title":"Reactivation of IgA vasculitis following COVID-19 vaccination","volume":"14","author":"Maye","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"9","key":"2026012110230071000_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(21)00211-3","article-title":"Reactivation of IgA vasculitis after COVID-19 vaccination","volume":"3","author":"Obeid","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"2026012110230071000_CR36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.kint.2021.05.017","article-title":"ANCA glomerulonephritis after the Moderna COVID-19 vaccination","volume":"100","author":"Sekar","year":"2021","journal-title":"Kidney Int"},{"key":"2026012110230071000_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.08.006","article-title":"Membranous nephropathy following anti-Covid-19 mRNA vaccination","author":"Gueguen","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"2026012110230071000_CR38","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.kint.2021.05.007","article-title":"Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine","volume":"100","author":"Holzworth","year":"2021","journal-title":"Kidney Int"},{"key":"2026012110230071000_CR39"},{"issue":"2","key":"2026012110230071000_CR40","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/cjn.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2026012110230071000_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00467-017-3677-5","article-title":"Immunology of idiopathic nephrotic syndrome","volume":"33","author":"Colucci","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"2026012110230071000_CR42","first-page":"246","article-title":"Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination","volume":"54","author":"Kielstein","year":"2000","journal-title":"Clin Nephrol"},{"issue":"5841","key":"2026012110230071000_CR43","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/bmj.4.5841.665-a","article-title":"Measles vaccination and the nephrotic syndrome","volume":"4","author":"Kuzemko","year":"1972","journal-title":"BMJ"},{"key":"2026012110230071000_CR44","first-page":"349","article-title":"Nephrotic syndrome after recombinant hepatitis B vaccine","volume":"43","author":"Mac\u00e1rio","year":"1995","journal-title":"Clin Nephrol"},{"issue":"07","key":"2026012110230071000_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5414\/cnp58068","article-title":"Minimal change nephrotic syndrome, lymphadenopathy and hyperimmunoglobulinemia after immunization with a pneumococcal vaccine","volume":"58","author":"Kikuchi","year":"2002","journal-title":"Clin Nephrol"},{"key":"2026012110230071000_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Articles Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","author":"Folegatti","year":"2020","journal-title":"The Lancet"},{"issue":"7868","key":"2026012110230071000_CR47","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"issue":"1","key":"2026012110230071000_CR48","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1038\/s41467-020-18319-6","article-title":"Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"key":"2026012110230071000_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-01970-y","article-title":"Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases","author":"Gupta","year":"2020","journal-title":"BMC Nephrol"},{"issue":"10","key":"2026012110230071000_CR50","first-page":"1129","article-title":"Nephrotic syndrome in adults: diagnosis and management","volume":"80","author":"Kodner","year":"2009","journal-title":"Am Fam Physician"},{"key":"2026012110230071000_CR51"},{"issue":"7654","key":"2026012110230071000_CR52","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/bmj.39576.709711.80","article-title":"Nephrotic syndrome in adults","volume":"336","author":"Hull","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"2026012110230071000_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7861\/clinmed.2021-0472","article-title":"Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist","volume":"22","author":"Hull","year":"2022","journal-title":"Clin Med"},{"issue":"10","key":"2026012110230071000_CR54","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1093\/ckj\/sfab123","article-title":"Minimal change disease following vaccination with CoronaVac","volume":"14","author":"Dirim","year":"2021","journal-title":"Clin Kidney J"},{"issue":"2","key":"2026012110230071000_CR55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s40746-016-0044-x","article-title":"Nephrotic syndrome: updates and approaches to treatment","volume":"2","author":"Rheault","year":"2016","journal-title":"Curr Treat Opt Pediatr"},{"issue":"10","key":"2026012110230071000_CR56","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.4049\/jimmunol.2100637","article-title":"Cutting edge: circulating exosomes with COVID spike protein are induced by BNT162b2 (Pfizer-BioNTech) vaccination prior to development of antibodies: a novel mechanism for immune activation by mRNA vaccines","volume":"207","author":"Bansal","year":"2021","journal-title":"J Immunol"},{"issue":"6","key":"2026012110230071000_CR57","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.18505","article-title":"Epidemiology of myocarditis and pericarditis following mRNA vaccination by vaccine product, schedule, and interdose interval among adolescents and adults in Ontario, Canada","volume":"5","author":"Buchan","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"13","key":"2026012110230071000_CR58","doi-asserted-by":"publisher","first-page":"6940","DOI":"10.3390\/ijms23136940","article-title":"Intramyocardial inflammation after COVID-19 vaccination: an endomyocardial biopsy-proven case series","volume":"23","author":"Baumeier","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01710-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-023-01710-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/36\/9\/2431\/66512424\/joneph_36_9_1710.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01710-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/36\/9\/2431\/66512424\/joneph_36_9_1710.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:23:11Z","timestamp":1769008991000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/36\/9\/2431\/8303670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,7,28]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1007\/s40620-023-01710-z","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,1]]},"published":{"date-parts":[[2023,7,28]]},"assertion":[{"value":"18 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Approval from the institutional review board was not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"For this retrospective review, formal consent is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}